click below
click below
Normal Size Small Size show me how
PHO 1
PAIN, HEMATOLOGY, AND ONCOLOGY 1
| brand | generic | category | class | indication | key side effects | box warning | other notes |
|---|---|---|---|---|---|---|---|
| Transdermal: Duragesic, IV: Sublimaze | fentanyl (transdermal, IV) | Opioid analgesic | CS - II | Pain | Key Side Effects: dizziness, drowsiness, nausea, vomiting, constipation, pruritus, respiratory depression (dose-related) | US Boxed Warning (only for fentanyl): potential for medication errors when converting between dosage forms; use with CYP3A4 inhibitors (or stopping CYP3A4 inducers) can increase fentanyl concentrations; avoid exposing transdermal patch to external heat | |
| Dilaudid | hydromorphone (PO, IV) | Opioid analgesic | CS - II | Pain | Key Side Effects: dizziness, drowsiness, nausea, vomiting, constipation, pruritus, respiratory depression (dose-related) | US Boxed Warning (only for hydromorphone): risk of medication errors with high-potency hydromorphone, use in opioid-tolerant patients only | |
| MS Contin, Kadian | morphine (extended release)(PO) | Opioid analgesic | CS - II | Pain | Key Side Effects: dizziness, drowsiness, nausea, vomiting, constipation, pruritus, respiratory depression (dose-related) | US Boxed Warning (only for morphine, extended release): coingestion with alcohol may result in potentially fatal overdose of morphine | |
| IV: Duramorph, Infumorph | morphine (immediate release) (PO, IV, IM, PR) | Opioid analgesic | CS - II | Pain | Key Side Effects: dizziness, drowsiness, nausea, vomiting, constipation, pruritus, respiratory depression (dose-related) | ||
| OxyContin, Roxicodone | oxycodone (PO) | Opioid analgesic | CS - II | Pain | Key Side Effects: dizziness, drowsiness, nausea, vomiting, constipation, pruritus, respiratory depression (dose-related) | US Boxed Warning (only for oxycodone): use with CYP3A4 inhibitors (or stopping CYP3A4 inducers) can increase oxycodone concentrations | |
| Dolophine | methadone (PO, IV) | Opioid analgesic | CS - II | Opioid use disorder, severe chronic pain | Key Side Effects: dizziness, drowsiness, nausea, vomiting, constipation, respiratory depression (dose-related), QTc prolongation | QTc interval prolongation and serious arrhythmia (Torsades de Pointes) have occurred during treatment; concomitant use with CYP3A4, 2B6, 2C19, or 2D6 (or stopping the same inducers) can increase methadone concentrations | |
| PO/PR: Tylenol, IV: Ofirmev | acetaminophen (PO, PR, IV) | Analgesic (non-opioid), antipyretic | PO, PR: OTC | Pain, fever | Key Side Effects: nausea, vomiting, increased hepatic transaminases | US Boxed Warnings: total daily dose from all sources should not exceed maximum daily limit; hepatotoxicity | |
| Ultram, Ultram ER | tramadol (PO) | Central analgesic; partial opioid agonist | CS -IV | Pain | Key Side Effects: dizziness, drowsiness, nausea, vomiting, constipation, respiratory depression (dose-related) | Other Notes: lowers seizure threshold PR: per rectum |